Learn more

SUZHOU RES INST OF TONGJI UNIV

Overview
  • Total Patents
    24
  • GoodIP Patent Rank
    69,336
About

SUZHOU RES INST OF TONGJI UNIV has a total of 24 patent applications. Its first patent ever was published in 2015. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are REPUBLIC KOREA MAN ANIMAL & PLANT QUARANTINE AGENCY, LI YUEXI and CT FOR DNA FINGERPRINTING AND.

Patent filings in countries

World map showing SUZHOU RES INST OF TONGJI UNIVs patent filings in countries
# Country Total Patents
#1 China 24

Patent filings per year

Chart showing SUZHOU RES INST OF TONGJI UNIVs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Jiang Ming 23
#2 Yu Lihua 16
#3 Guo Jia 15
#4 Jiang Yun 13
#5 Yin Yanxin 13
#6 Liu Minya 4
#7 Zhang Cheng 4
#8 Mao Yuting 4
#9 Wang Le 3
#10 Fang Jianmin 2

Latest patents

Publication Filing date Title
CN106399378A PLC (phospholipase C) epsilon gene targeted RNA-interference recombinant lentiviral vectors and construction method thereof
CN106480098A Targeting VEGFA gene RNA interference recombinant lentivirus vector and its construction method
CN106434858A Primer composition for detecting Claudin5 gene expression level and application of primer composition
CN106086163A A kind of primer for detecting humanized BCL 2 gene expression dose combines and application
CN106085963A A kind of HSP70 interference stability cell line for PD research and method for building up thereof
CN105924524A Anti-c-Met chimeric antibody and application thereof
CN105925611A RNA interference recombinant lentiviral vectors targeting HSP70 gene and construction method of RNA interference recombinant lentiviral vectors
CN105925532A Anti-tumor-migration drug screening cell model HBL-100-GFP constructed by adopting lentivirus technology and application method of anti-tumor-migration drug screening cell model HBL-100-GFP
CN106167819A A kind of primer for detecting humanized's BAX gene expression dose combines and application
CN105925673A Anti-tumor-migration drug screening cell model EA-GFP constructed by adopting lentivirus technology and application method of anti-tumor-migration drug screening cell model EA-GFP
CN105884897A Quick expression of slow viruses by aid of c-Met-resistant univalent antibody and application thereof
CN105925533A Anti-tumor-migration drug screening cell model A549-GFP constructed by adopting lentivirus technology and application method of anti-tumor-migration drug screening cell model A549-GFP
CN105925534A Anti-tumor-migration drug screening cell model U87-MG-GFP constructed by adopting lentivirus technology and application method of anti-tumor-migration drug screening cell model U87-MG-GFP
CN105925531A Anti-tumor-migration drug screening cell model MDA-MB-231-GFP constructed by adopting lentivirus technology and application method of anti-tumor-migration drug screening cell model MDA-MB-231-GFP
CN105924523A Anti-c-Met single chain variable fragment and application thereof
CN105936917A GRP78 gene targeted RNA interference recombinant lentivirus vectors and construction method
CN105754950A Cell model MCF-7-GFP used for screening anti-tumor-migration drugs and built by lentivirus technology and application of cell model MCF-7-GFP
CN106148507A A kind of primer for detecting humanized's X box binding protein 1s gene expression dose combines and application
CN105755142A Primer-probe combination for detecting expression level of human axin2 genes
CN105779623A Primer combination for detecting expression level of human-derived activating transcription factor-4 gene and application of primer combination